DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisolone (Prednisolone) - Pneumocystis Jiroveci Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumocystis Jiroveci Pneumonia (98)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include pneumocystis jiroveci pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 98   Next >>

Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-27

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-27

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (4 standard cycles)

Cyclophosphamide
    Dosage: 650 mg/m2, day 1 (4 standard cycles)

Cyclophosphamide
    Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2, day 1 (4 standard cycles)

Doxorubicin HCL
    Dosage: 35 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100 mg/m2, day 1-3 (4 standard cycles)

Etoposide
    Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
    Administration route: Oral

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
    Administration route: Oral

Vincristine
    Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (4 standard cycles)



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-24

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-23

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s

Cyclophosphamide

Cyclophosphamide

Doxorubicin Hydrochloride

Doxorubicin Hydrochloride

Etoposide

Etoposide

Prednisolone
    Administration route: Oral

Procarbazine Hydrochloride
    Administration route: Oral

Vincristine



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-08-09

Patient: male

Reactions: Pneumocystis Jiroveci Pneumonia

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisolone
    Dosage: 5 mg, uid/qd
    Administration route: Oral
    Indication: Interstitial Lung Disease
    Start date: 2010-04-20
    End date: 2010-06-24

Prednisolone
    Indication: Rheumatoid Arthritis

Prograf
    Indication: Interstitial Lung Disease

Prograf
    Dosage: 0.5 mg, tid
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2010-06-15
    End date: 2010-06-24

Other drugs received by patient: Lansoprazole; Lansoprazole



Possible Prednisolone side effects in 74 year old male

Reported by a physician from Japan on 2012-08-07

Patient: 74 year old male, weighing 50.0 kg (110.0 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisolone
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-10-18
    End date: 2011-12-30

Romiplostim - KHK
    Dosage: 1 mug/kg, qd
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-11-21
    End date: 2011-11-21



Possible Prednisolone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-07-31

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Lung Infiltration, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650mg/m2
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: 25 mg/m2, unk
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100 mg/m2, unk
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m2
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, unk
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, unk
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in

Reported by a physician from Korea, Republic of on 2012-07-30

Patient:

Reactions: Pneumocystis Jiroveci Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 6.5 unk, unk
    Start date: 2011-12-20
    End date: 2012-06-26

Melphalan Hydrochloride
    Dosage: 9 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-09-18
    End date: 2011-09-21

Melphalan Hydrochloride
    Dosage: 9 mg/m2, unk
    Start date: 2011-10-31
    End date: 2011-11-03

Prednisolone
    Dosage: 45 mg/m2, unk
    Start date: 2011-12-20
    End date: 2012-06-26

Prednisolone
    Dosage: 60 mg/m2, unk
    Start date: 2011-10-31
    End date: 2011-11-03

Prednisolone
    Dosage: 60 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-09-18
    End date: 2011-09-21

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-09-08
    End date: 2011-10-20

Velcade
    Dosage: 1.0 mg/m2, unk
    Start date: 2011-10-31
    End date: 2012-06-21



Possible Prednisolone side effects in 73 year old male

Reported by a physician from Japan on 2012-07-27

Patient: 73 year old male, weighing 58.0 kg (127.6 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Intentional Drug Misuse

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisolone
    Dosage: 25 mg, bid, oral
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Prograf
    Dosage: 1 mg, uid/qd, oral : 1.5 mg, uid/qd, oral
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-06-11
    End date: 2008-11-18

Prograf
    Dosage: 1 mg, uid/qd, oral : 1.5 mg, uid/qd, oral
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-11-19

Rheumatrex
    Dosage: oral
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    End date: 2009-01-28

Other drugs received by patient: Celecoxib



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-07-19

Patient: female

Reactions: Pneumocystis Jiroveci Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    End date: 2012-07-03

Simponi
    Indication: Rheumatoid Arthritis
    Start date: 2011-11-01

Simponi
    Start date: 2012-06-05
    End date: 2012-06-05

Other drugs received by patient: Celebrex



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Enterococcal Infection, Coagulopathy, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Pneumocystis Jiroveci Pneumonia, Anal Fistula, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Gastrointestinal Ulcer Haemorrhage, Restlessness, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Large Intestinal Ulcer, Ileal Fistula, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Anal Haemorrhage, Purulence, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Other drugs received by patient: Insulin



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Disseminated Intravascular Coagulation, Enterococcal Infection, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Anaemia, Hyperglycaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Ileal Fistula, Large Intestinal Ulcer, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Purulence, Anal Haemorrhage, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Other drugs received by patient: Insulin



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-07-16

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Intentional Drug Misuse

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisolone
    Dosage: 2.5 mg, bid
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Prograf
    Dosage: 1 mg, uid/qd
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-06-11
    End date: 2008-11-18

Prograf
    Dosage: 1.5 mg, uid/qd
    Administration route: Oral
    Start date: 2008-11-19

Rheumatrex
    Dosage: unk
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    End date: 2009-01-28

Other drugs received by patient: Celebrex



Possible Prednisolone side effects in 16 year old female

Reported by a physician from Japan on 2012-07-16

Patient: 16 year old female

Reactions: Pneumocystis Jiroveci Pneumonia, Drug Ineffective

Drug(s) suspected as cause:
Cyclosporine
    Indication: Juvenile Arthritis
    Start date: 2006-01-01

Etanercept
    Indication: Juvenile Arthritis
    End date: 2007-08-01

Methylprednisolone
    Start date: 2006-01-01
    End date: 2006-01-01

Methylprednisolone
    Indication: Juvenile Arthritis
    Start date: 2006-01-01
    End date: 2006-01-01

Prednisolone
    Indication: Juvenile Arthritis
    Start date: 2006-01-01

Remicade
    Indication: Juvenile Arthritis

Remicade
    Indication: Histiocytosis Haematophagic

Rheumatrex
    Administration route: Oral
    Indication: Juvenile Arthritis
    Start date: 2006-11-01
    End date: 2007-08-01

Tacrolimus
    Indication: Juvenile Arthritis
    Start date: 2006-01-01



Possible Prednisolone side effects in

Reported by a physician from Korea, Republic of on 2012-07-16

Patient:

Reactions: Pneumocystis Jiroveci Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 9 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-09-18
    End date: 2011-09-21

Melphalan Hydrochloride
    Dosage: 6.5 unk, unk
    Start date: 2011-12-20
    End date: 2012-06-26

Melphalan Hydrochloride
    Dosage: 9 mg/m2, unk
    Start date: 2011-10-31
    End date: 2011-11-03

Prednisolone
    Dosage: 60 mg/m2, unk
    Start date: 2011-10-31
    End date: 2011-11-03

Prednisolone
    Dosage: 45 mg/m2, unk
    Start date: 2011-12-20
    End date: 2012-06-26

Prednisolone
    Dosage: 60 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-09-18
    End date: 2011-09-21

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-09-08
    End date: 2011-10-20

Velcade
    Dosage: 1.0 mg/m2, unk
    Start date: 2011-10-31
    End date: 2012-06-21



Possible Prednisolone side effects in 16 year old female

Reported by a physician from Japan on 2012-07-13

Patient: 16 year old female

Reactions: Pneumocystis Jiroveci Pneumonia, Drug Ineffective

Drug(s) suspected as cause:
Cyclosporine
    Indication: Juvenile Arthritis
    Start date: 2006-01-01

Etanercept
    Indication: Juvenile Arthritis
    End date: 2007-08-01

Methylprednisolone
    Start date: 2006-01-01
    End date: 2006-01-01

Methylprednisolone
    Indication: Juvenile Arthritis
    Start date: 2006-01-01
    End date: 2006-01-01

Prednisolone
    Indication: Juvenile Arthritis
    Start date: 2006-01-01

Remicade
    Indication: Juvenile Arthritis

Remicade
    Indication: Histiocytosis Haematophagic

Rheumatrex
    Administration route: Oral
    Indication: Juvenile Arthritis
    Start date: 2006-11-01
    End date: 2007-08-01

Tacrolimus
    Indication: Juvenile Arthritis
    Start date: 2006-01-01



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-11

Patient: male, weighing 50.0 kg (110.0 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Lymphoma
    Start date: 2011-01-13

Doxorubicin HCL
    Indication: Lymphoma
    Start date: 2011-01-13

Mabthera
    Indication: Lymphoma
    Start date: 2011-01-13

Prednisolone
    Dosage: 40 mg/m2;
    Administration route: Oral
    Indication: Lymphoma
    Start date: 2011-01-13
    End date: 2011-01-17

Vincristine
    Indication: Lymphoma
    Start date: 2011-01-13

Other drugs received by patient: Nexium



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-07-10

Patient: female, weighing 37.5 kg (82.5 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Cytomegalovirus Infection, Ileus Paralytic

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 120 mg/m2;
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-24
    End date: 2011-08-25

Bendamustine Hydrochloride
    Dosage: 120 mg/m2;
    Start date: 2011-09-13

Cyclophosphamide
    Dosage: 490 milligram;
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-07-26

Prednisolone
    Dosage: 80 milligram;
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-07-26

Rituximab
    Dosage: 490 milligram;
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-07-26

Vincristine Sulfate
    Dosage: .9 milligram;
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-07-26

Other drugs received by patient: Palonosetron Hydrochloride; Granisetron Hydrochloride; Cefmetazole Sodium; Tazobactam; Granisetron Hydrochloride; Platelets



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-07-10

Patient: female

Reactions: Pneumocystis Jiroveci Pneumonia, Hypoxia, Blood Beta-D-Glucan Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Humira
    Indication: Rheumatoid Arthritis
    Start date: 2010-07-14
    End date: 2010-09-08

Prednisolone
    Indication: Product Used FOR Unknown Indication

Promacta
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Methotrexate; Prednisolone; Methotrexate; Prednisolone



Possible Prednisolone side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-07-06

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Diarrhoea, Interstitial Lung Disease, Pneumonia Pneumococcal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Actemra
    Start date: 2009-11-20
    End date: 2011-02-07

Actemra
    Start date: 2011-06-01
    End date: 2011-06-01

Actemra
    Indication: Rheumatoid Arthritis
    Start date: 2009-07-21
    End date: 2009-07-21

Actemra
    Start date: 2011-04-15
    End date: 2011-04-15

Methotrexate
    Dosage: form: peroral agent
    Administration route: Oral
    Start date: 2008-03-14
    End date: 2008-05-15

Methotrexate
    Dosage: form: peroral agent
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2007-01-01
    End date: 2008-03-14

Methotrexate
    Dosage: form: peroral agent
    Administration route: Oral

Prednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Other drugs received by patient: Loxonin; Mucosta; Omeprazole; Risedronate Sodium



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-07-05

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisolone
    Dosage: 2.5 mg, bid
    Administration route: Oral

Prograf
    Indication: Rheumatoid Arthritis

Rheumatrex
    Dosage: unk
    Administration route: Oral
    End date: 2009-01-28

Other drugs received by patient: Celebrex



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-07-02

Patient: female, weighing 37.5 kg (82.5 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Cytomegalovirus Infection, Ileus Paralytic

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 120 mg/m2;
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-24
    End date: 2011-08-25

Bendamustine Hydrochloride
    Dosage: 120 mg/m2;
    Start date: 2011-09-13

Cyclophosphamide
    Dosage: 490 milligram;
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-07-26

Prednisolone
    Dosage: 80 milligram;
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-07-26

Rituximab
    Dosage: 490 milligram;
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-07-26

Vincristine Sulfate
    Dosage: .9 milligram;
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-07-26

Other drugs received by patient: Granisetron Hydrochloride; Palonosetron Hydrochloride; Granisetron Hydrochloride; Tazobactam; Cefmetazole Sodium; Piperacillin Sodium W / Tazobactam



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-06-27

Patient: female, weighing 33.0 kg (72.6 pounds)

Reactions: Histiocytosis Haematophagic, Gastric Ulcer Haemorrhage, Shock Haemorrhagic, Device Related Infection, Staphylococcal Sepsis, Oral Herpes, Haemothorax, Pneumocystis Jiroveci Pneumonia, Pneumothorax, Juvenile Arthritis

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Actemra
    Start date: 2009-09-09

Actemra
    Indication: Juvenile Arthritis
    Start date: 2009-04-21
    End date: 2011-12-28

Actemra
    Start date: 2012-01-04
    End date: 2012-01-26

Actemra
    Start date: 2012-02-10
    End date: 2012-02-24

Actemra
    Start date: 2009-07-28
    End date: 2009-08-26

Cyclosporine
    Indication: Histiocytosis Haematophagic
    Start date: 2012-02-27
    End date: 2012-03-11

Cyclosporine
    Indication: Juvenile Arthritis
    Start date: 2011-12-30
    End date: 2012-01-05

Dexamethasone
    Start date: 2012-01-04
    End date: 2012-01-04

Dexamethasone
    Start date: 2009-02-16
    End date: 2009-04-13

Dexamethasone
    Indication: Juvenile Arthritis
    Start date: 2009-02-05
    End date: 2009-02-05

Dexamethasone
    Start date: 2009-02-09
    End date: 2009-02-09

Dexamethasone
    Start date: 2009-02-12
    End date: 2009-02-12

Methylprednisolone
    Start date: 2009-01-26
    End date: 2009-01-28

Methylprednisolone
    Dosage: uncertain dosage and three cool
    Start date: 2011-01-01
    End date: 2011-01-01

Methylprednisolone
    Dosage: uncertain dosage and three cool
    Indication: Juvenile Arthritis
    Start date: 2008-01-01
    End date: 2008-01-01

Methylprednisolone
    Start date: 2009-02-02
    End date: 2009-02-04

Methylprednisolone
    Start date: 2011-12-30
    End date: 2012-01-01

Methylprednisolone
    Start date: 2012-01-06
    End date: 2012-01-08

Methylprednisolone
    Start date: 2012-01-13
    End date: 2012-01-15

Methylprednisolone
    Start date: 2012-02-27
    End date: 2012-02-29

Methylprednisolone
    Start date: 2009-01-19
    End date: 2009-01-21

Prednisolone
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2009-01-01

Prednisolone
    Administration route: Oral
    Start date: 2009-06-02
    End date: 2009-06-08

Prednisolone
    Administration route: Oral
    Start date: 2009-08-12
    End date: 2009-08-18

Prednisolone
    Administration route: Oral
    Start date: 2010-01-06
    End date: 2010-02-02

Prednisolone
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-12-27

Prednisolone
    Administration route: Oral
    Start date: 2012-01-09
    End date: 2012-01-12

Prednisolone
    Administration route: Oral
    Start date: 2012-02-20
    End date: 2012-02-26

Prednisolone
    Administration route: Oral
    Start date: 2009-06-30
    End date: 2009-06-30

Prednisolone
    Administration route: Oral
    Start date: 2011-12-28
    End date: 2011-12-29

Prednisolone
    Administration route: Oral
    Start date: 2012-01-23
    End date: 2012-02-05

Prednisolone
    Administration route: Oral
    Start date: 2009-01-29
    End date: 2009-02-01

Prednisolone
    Administration route: Oral
    Start date: 2009-06-09
    End date: 2009-06-15

Prednisolone
    Administration route: Oral
    Start date: 2009-06-16
    End date: 2009-06-22

Prednisolone
    Administration route: Oral
    Start date: 2009-07-01
    End date: 2009-07-13

Prednisolone
    Administration route: Oral
    Start date: 2012-01-02
    End date: 2012-01-05

Prednisolone
    Administration route: Oral
    Start date: 2009-08-26
    End date: 2009-09-23

Prednisolone
    Administration route: Oral
    Start date: 2009-09-24
    End date: 2009-10-20

Prednisolone
    Administration route: Oral
    Start date: 2009-11-18
    End date: 2010-01-05

Prednisolone
    Administration route: Oral
    Start date: 2012-02-13
    End date: 2012-02-19

Prednisolone
    Administration route: Oral
    Start date: 2009-01-22
    End date: 2009-01-25

Prednisolone
    Administration route: Oral
    Start date: 2009-08-19
    End date: 2009-08-25

Prednisolone
    Administration route: Oral
    Start date: 2009-10-21
    End date: 2009-11-17

Prednisolone
    Administration route: Oral
    Start date: 2012-02-06
    End date: 2012-02-12

Prednisolone
    Administration route: Oral
    Start date: 2009-02-05
    End date: 2009-02-08

Prednisolone
    Administration route: Oral
    Start date: 2009-02-09
    End date: 2009-05-28

Prednisolone
    Administration route: Oral
    Start date: 2009-05-29
    End date: 2009-06-01

Prednisolone
    Administration route: Oral
    Start date: 2009-07-28
    End date: 2009-08-11

Prednisolone
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Prednisolone
    Administration route: Oral
    Start date: 2012-01-21
    End date: 2012-01-22

Prednisolone
    Administration route: Oral
    Indication: Juvenile Arthritis
    Start date: 2008-01-01
    End date: 2008-01-01

Prednisolone
    Administration route: Oral
    Start date: 2009-06-23
    End date: 2009-06-29

Prednisolone
    Administration route: Oral
    Start date: 2010-02-03
    End date: 2011-01-01

Prednisolone
    Administration route: Oral
    Start date: 2009-07-14
    End date: 2009-07-27

Prednisolone
    Administration route: Oral
    Start date: 2012-01-16
    End date: 2012-01-20

Tacrolimus
    Administration route: Oral
    Indication: Juvenile Arthritis
    Start date: 2009-02-09
    End date: 2009-02-16

Tacrolimus
    Administration route: Oral
    Start date: 2009-05-22

Tacrolimus
    Administration route: Oral
    Start date: 2012-01-23
    End date: 2012-02-19

Tacrolimus
    Administration route: Oral
    Start date: 2009-02-17
    End date: 2009-02-19

Tacrolimus
    Administration route: Oral
    Start date: 2012-01-16
    End date: 2012-01-20

Tacrolimus
    Administration route: Oral
    Start date: 2009-02-20
    End date: 2009-05-21

Other drugs received by patient: Depakene; Adalat CC; Enalapril Maleate; Ibruprofen; Famotidine; Colchicine; Actonel; Alfarol; Methotrexate; Foliamin; Clobazam; Colchicine



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-06-25

Patient: female, weighing 48.0 kg (105.6 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Bronchopulmonary Aspergillosis, Cytomegalovirus Enterocolitis, Drug Ineffective

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 25 mg, unknown/d
    Administration route: Oral
    End date: 2012-06-01

Prednisolone
    Dosage: unk
    Administration route: Oral
    Indication: Colitis Ulcerative
    Start date: 2009-12-22

Prograf
    Dosage: 2.5 mg, bid
    Administration route: Oral
    Indication: Colitis Ulcerative
    Start date: 2012-03-07
    End date: 2012-05-13

Remicade
    Dosage: unk
    Indication: Colitis Ulcerative
    Start date: 2012-02-14
    End date: 2012-02-28

Other drugs received by patient: Pentasa; Lipitor; Evista; Famotidine; Lansoprazole; Pentasa; Bitsan; Norvasc



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-06-14

Patient: 49 year old male

Reactions: Off Label Use, Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate

Cyclophosphamide

Doxorubicin HCL

Etoposide

Prednisolone
    Administration route: Oral

Procarbazine Hydrochloride
    Administration route: Oral

Vincristine



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-06-13

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Hyperlipidaemia, Peripheral Arterial Occlusive Disease, Arrhythmia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Actemra
    Dosage: dosage is uncertain.
    Indication: Rheumatoid Arthritis
    Start date: 2011-06-21
    End date: 2012-02-02

Prednisolone
    Dosage: 2mg ,10mg
    Administration route: Oral
    Indication: Rheumatoid Vasculitis
    Start date: 2003-01-01

Rheumatrex
    Administration route: Oral

Rheumatrex
    Administration route: Oral
    Indication: Rheumatoid Vasculitis
    Start date: 2003-08-01

Rheumatrex
    Administration route: Oral

Other drugs received by patient: Azulfidine; Aspara-CA; Actonel; Cytotec; Foliamin; Rimatil; Marzulene-S; Miya BM; Rabeprazole Sodium; Mobic; Onealfa; Voltaren



Possible Prednisolone side effects in 64 year old female

Reported by a physician from Japan on 2012-06-12

Patient: 64 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Gastrointestinal Haemorrhage, Gastritis Erosive, Constipation, Liver Disorder, Pneumocystis Jiroveci Pneumonia, Ileus, Oedema, Gastrooesophageal Reflux Disease, Renal Failure Acute, Decreased Appetite, White Blood Cell Count Decreased, Vomiting, Stomatitis, Nausea, Anaemia, Febrile Neutropenia, Diarrhoea, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Marzulene-S
    Dosage: 3 packs
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-05-19
    End date: 2009-08-18

Omeprazole
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-05-19
    End date: 2009-05-25

Oncovin
    Dosage: 20may09-20may09 27may09-27may09 03jun09-03jun09 10jun09-10jun09 14aug09-14aug09
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-05-20
    End date: 2009-08-14

Prednisolone
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-05-27
    End date: 2009-06-16

Sprycel
    Dosage: therapy interrupted on 04sep09,restarted on 24sep09.
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-05-27
    End date: 2009-10-09

Other drugs received by patient: Granisetron HCL; Doxorubicin HCL; Leucovorin Calcium; Uralyt; Bactrim; Potassium Citrate; Cyclophosphamide; Sulbactam Sodium; Acetazolamide; Gasmotin; Sodium Citrate; Diart; Methylprednisolone Sodium Succinate; Neuquinon; Cytarabine; Oren-Gedoku-TO; Trimethoprim; Dexamethasone Sodium Phosphate; Ampicillin Sodium; Mosapride Citrate; Granisetron HCL; Methotrexate; Amikacin Sulfate; Carbazochrome Sodium Sulfonate; Amino Acid INJ; Miya-BM; Aldactone; Maxipime



Possible Prednisolone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-06-11

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on d8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650mg/m2 standard cycles 1250 for the escalated cycles
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 35mg/m2,on d1 for escalated cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100mg/m2 for the standard cycles d1 to 3; 200mg/m2 for the escalated cycles from d1-3 iv
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on days 1 to 14 in every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day1-7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on d8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-06-08

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (4 standard cycles)

Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650 mg/m2, day 1 (4 standard cycles)

Doxorubicin HCL
    Dosage: 35 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2, day 1 (4 standard cycles)

Etoposide
    Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100 mg/m2, day 1-3 (4 standard cycles)

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
    Administration route: Oral

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
    Administration route: Oral

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (4 standard cycles)



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-06-08

Patient: female, weighing 33.0 kg (72.6 pounds)

Reactions: Histiocytosis Haematophagic, Gastric Ulcer Haemorrhage, Shock Haemorrhagic, Device Related Infection, Staphylococcal Sepsis, Oral Herpes, Haemothorax, Pneumocystis Jiroveci Pneumonia, Pneumothorax, Juvenile Arthritis

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Actemra
    Start date: 2012-01-04
    End date: 2012-01-26

Actemra
    Start date: 2012-02-10
    End date: 2012-02-24

Actemra
    Indication: Juvenile Arthritis
    Start date: 2009-04-21
    End date: 2011-12-28

Actemra
    Start date: 2009-09-09

Actemra
    Start date: 2009-07-28
    End date: 2009-08-26

Cyclosporine
    Indication: Juvenile Arthritis
    Start date: 2011-12-30
    End date: 2012-01-05

Cyclosporine
    Indication: Histiocytosis Haematophagic
    Start date: 2012-02-27
    End date: 2012-03-11

Dexamethasone
    Indication: Juvenile Arthritis
    Start date: 2012-01-04
    End date: 2012-01-04

Methylprednisolone Sodium Succinate
    Start date: 2012-02-27
    End date: 2012-02-29

Methylprednisolone Sodium Succinate
    Indication: Juvenile Arthritis
    Start date: 2011-12-30
    End date: 2012-01-01

Methylprednisolone Sodium Succinate
    Start date: 2012-01-06
    End date: 2012-01-08

Methylprednisolone Sodium Succinate
    Start date: 2012-01-13
    End date: 2012-01-15

Prednisolone
    Administration route: Oral
    Start date: 2012-02-20
    End date: 2012-02-26

Prednisolone
    Administration route: Oral
    Start date: 2012-01-02
    End date: 2012-01-05

Prednisolone
    Administration route: Oral
    Start date: 2012-01-21
    End date: 2012-01-22

Prednisolone
    Administration route: Oral
    Start date: 2012-02-13
    End date: 2012-02-19

Prednisolone
    Administration route: Oral
    Start date: 2012-01-16
    End date: 2012-01-20

Prednisolone
    Administration route: Oral
    Indication: Juvenile Arthritis
    Start date: 2011-12-28
    End date: 2011-12-29

Prednisolone
    Administration route: Oral
    Start date: 2012-01-09
    End date: 2012-01-12

Prednisolone
    Administration route: Oral
    Start date: 2012-01-23
    End date: 2012-02-05

Prednisolone
    Administration route: Oral
    Start date: 2012-02-06
    End date: 2012-02-12

Tacrolimus
    Administration route: Oral
    Indication: Juvenile Arthritis
    Start date: 2012-01-16
    End date: 2012-01-20

Tacrolimus
    Administration route: Oral
    Start date: 2012-01-23
    End date: 2012-02-19

Other drugs received by patient: Clobazam; Alfarol; Actonel; Enalapril Maleate; Depakene; Methotrexate; Foliamin; Ibruprofen; Adalat CC; Colchicine; Colchicine



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017